DCM Shriram Profit: Tax ka Kamaal, Par Stock Gira? Shareholders ki Pareshani Badhi!

CHEMICALS
Whalesbook Logo
AuthorIshaan Verma|Published at:
DCM Shriram Profit: Tax ka Kamaal, Par Stock Gira? Shareholders ki Pareshani Badhi!
Overview

DCM Shriram ne Q4 mein kamaal kar diya, profit toh **107%** bhaga diya! Apni Q4 FY26 results mein company ne **₹370 crore** ka Net Profit report kiya hai. Lekin, yeh sab tax reversal ki wajah se hua, warna core operations par pressure dikh raha hai aur stock **4.5%** gir bhi gaya.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Tax Ka Jadoo Ya Asli Performance?

So, DCM Shriram ka Q4 FY26 ka result aaya hai aur Net Profit mein 107% ka zabardast jump dikha hai, lagbhag ₹370 crore tak. Lekin, bhai, yeh itna bada profit ek baar ke tax credit aur exceptional item reversal se aaya hai, jo lagbhag ₹117 crore tha. Agar yeh sab hatayein toh profit decline dikhata hai, matlab asli business mein operating margins tight ho rahe hain.

Revenue toh 11% badh kar ₹3,193 crore ho gaya, par badhti hui costs ne margins ko daba diya. Is wajah se investors thode chintit hain, aur stock May 14, 2026 ko 4.5% se zyada gir gaya. P Pichhle saal stock 7% se 15% tak bhaga tha, toh yeh dip investors ke liye warning bell hai ki profit sirf numbers mein hai, asli performance mein nahi.

Kaunsa Segment Chala, Kaunsa Thanda?

Chemicals business toh mast chal raha hai, poore fiscal year mein revenue 38% badha hai. Energy prices 9-10% badhne ke baad bhi, higher prices ne cost ko cover kar liya. Company Gujarat mein April 2026 mein ₹52,000 TPA Epichlorohydrin (ECH) plant bhi start kiya hai, chemical value chain ko expand karne ke liye.

Sugar aur agri side par export ban ka zyada impact nahi hua kyuki export revenue ka chhota hissa hai. Lekin, cane availability kam hone se production par asar pada hai. Agle saal better volumes ki umeed hai, weather par depend karta hai. El Niño ka risk agri sector ke liye ek concern hai.

Sabse zyada pressure Fenesta building systems division par hai. Turnover ₹1,100 crore ka hai, par margins 10% tak gir gaye hain, jo pehle 14% guide kiye gaye the. PVC, glass, aluminium jaise raw materials 15-60% mehange ho gaye hain, aur naye products par margins kam mil rahe hain. Company ko umeed hai ki 1-2 saal mein margins wapas 12-13% par aa jayenge.

Margin Pressure Aur Debt Ka Bojh

Overall, operating margins 11.13% par aa gaye hain, jo pehle 14.27% the. EBITDA margins bhi 10.5% se 13.4% tak kam ho gaye hain. Investors ko profit sustainability aur badhti hui input costs ki chinta hai jo Fenesta aur dusre sectors mein margins ko daba rahi hain. Chemicals mein diversification hai, par naye capacities abhi develop ho rahi hain. Agri-business mein El Niño ka risk bhi hai.

Net debt bhi badh kar ₹1,767 crore ho gaya hai, jo pichhle saal ₹1,395 crore tha. Yeh naye plants aur acquisitions mein investment ki wajah se hua hai.

Aage Kya? Investment Plan To Hai!

DCM Shriram ₹1,000-1,500 crore ka investment karne wala hai renewable energy, chlorine downstream, aluminium extrusion, aur high-tech polymer compounding mein. Toh long term strategy toh strong lag rahi hai, par short term mein margin pressure aur economic uncertainty investors ko pareshaan kar rahi hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.